dendritic cell vaccine for high risk ovarian cancer patients
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2005 (NCT00478452)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dendritic cell vaccine for high risk ovarian cancer patients
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00478452 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2005 | Temple University, University of Pennsylvania |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Temple University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2005 |
2 organizations
Page 1 / 1